Clinical Trial Update: Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient [Phase 3]

View source ↗

Summary

A multicentre Phase III trial evaluated the efficacy and safety of hetrombopag olamine in idiopathic thrombocytopenic purpura (ITP); the study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura

Drugs mentioned

• Hetrombopag Olamine (Hetrombopag)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Idiopathic Thrombocytopenic Purpura | Phase 3 | Status: COMPLETED